Impact of Kras Mutation on the Response and Prognosis of Patients with Stage III Non-Squamous Non-Small Cell Lung Cancer
Shigehiro Yagishita, T. Tamura(Waseda University), Takashi Kohno(Gunma University), Kenji Shiraishi(Nagoya University), Koh Furuta(Teikyo University Chiba Medical Center), Minako Sumi(Tokyo Metropolitan Geriatric Hospital), Yutaka Fujiwara(Aichi Cancer Center), Hidehito Horinouchi(Tokyo National Hospital), Kuniko Sunami(Tokyo National Hospital), N. Yamamoto, Shigeru Kanda(Nagoya Medical Center), K. Tsuta(National Cancer Center), Hiroshi Nokihara(Tokushima University Hospital)
Cited by 0
Related Papers
Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases
|Nature Genetics|2020|599
Feasibility and utility of a panel testing for 114 cancer‐associated genes in a clinical setting: A hospital‐based study
|Cancer Science|2019|375
A genome-wide association study identifies two new susceptibility loci for lung adenocarcinoma in the Japanese population
|Nature Genetics|2012|214
Radiation pneumonitis in lung cancer patients: a retrospective study of risk factors and the long-term prognosis
|International Journal of Radiation Oncology*Biology*Physics|2001|188